MedPath

A study to evaluate the effect of nasal administration of Brihat Shatavari Ghrita in the management of Premenstrual syndrome

Phase 3
Conditions
Health Condition 1: E319- Polyglandular dysfunction, unspecified
Registration Number
CTRI/2024/07/070654
Lead Sponsor
Dr Hitha M K
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Subjects diagnosed based on diagnostic criteria (Premenstrual Syndrome Scale)

Subjects having regular menstrual cycle (21-35 days)

Exclusion Criteria

Any diagnosed clinical condition that interferes with the clinical trial

Subjects under hormonal treatment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the add on effect of Brihat Shatavari Ghrita as Prathimarsha Nasya over Punarnavadi Kashaya and Ashwagandha Churna in Premenstrual SyndromeTimepoint: 21-35 days (after 1st menstrual cycle)
Secondary Outcome Measures
NameTimeMethod
To evaluate the combined effect of Brihat Shatavari Ghrita as Prathimarsha Nasya over Punarnavadi Kashaya and Ashwagandha Churna in Premenstrual SyndromeTimepoint: 21-35 days (after 1st menstrual cycle)
© Copyright 2025. All Rights Reserved by MedPath